Dec 11, 2025
New research — presented on Dec. 3 at the Radiological Society of North America meeting by Matthew Nudy, assistant professor of medicine and public health sciences at Penn State College of Medicine — suggest that routine mammograms could be a tool for evaluating cardiovascular disease risk in women.
Dec 10, 2025
Increasing colorectal cancer screening rates among communities with the greatest need is the goal of a five-year, $4.2 million grant from the Centers for Disease Control and Prevention (CDC) to Penn State College of Medicine.
Dec 9, 2025
Penn State College of Medicine researchers have received a $3.2 million NIH grant to help develop a small, durable heart pump designed specifically for children ages 1–11.
A team led by researchers from Penn State College of Medicine has developed a new method that substantially improves the ability to map the genetic variants that drive disease, particularly neurodegenerative diseases.
Nov 24, 2025
The Pediatric Cancer Center Barcelona (PCCB) at Hospital Sant Joan de Déu has become the first center outside North America to join the Beat Childhood Cancer (BCC) Research Consortium.
Nov 21, 2025
The annual Penn State College of Medicine Inflammatory Bowel Disease (IBD) Research Symposium was held this year at the Hershey Country Club on Friday, Oct. 10.
Nov 11, 2025
Penn State College of Medicine research teams recently received national funding awards to advance innovation in diagnostics, therapeutic research and sleep health.
Oct 31, 2025
This is the first high-resolution brain growth chart to explain changes of key brain cell types in the developing mouse brain, led by a team at Penn State College of Medicine and the Allen Institute for Brain Science.
Oct 20, 2025
Ten Penn State College of Medicine students have been selected to compete in the 2025 American Medical Association Research Challenge.
Oct 17, 2025
Researchers at Penn State College of Medicine, in collaboration with Aminex Therapeutics, Inc., today announced the start of a national pediatric clinical trial to evaluate an investigational treatment for children and young adults with neuroblastoma, central nervous system (CNS) tumors and sarcomas.